REVOLAX™ Fine with Lidocaine is a high-purity, monophasic dermal filler formulated with non-animal-based hyaluronic acid (HA). Developed by Across Co., Ltd. in South Korea, it is widely used in aesthetic medicine for the correction of superficial wrinkles and fine lines. Thanks to its lightweight viscosity, smooth consistency, and the presence of lidocaine for patient comfort, REVOLAX Fine is an ideal choice for facial areas requiring precision and subtle enhancement.
In the competitive market of dermal fillers, REVOLAX Fine stands out due to its affordability, performance, and CE certification for medical use in Europe. This makes it a suitable alternative to more expensive HA fillers for professionals looking for high-quality results without compromising patient safety or comfort.
This article offers a complete technical overview for professional injectors, including its composition, clinical indications, injection techniques, treatment zones, patient selection, safety considerations, and practical tips for improving results.
1. Composition and Properties
- Hyaluronic Acid Concentration: 24 mg/ml
- Lidocaine: 0.3% (for pain reduction during injection)
- Crosslinking Technology: Monophasic, densely cross-linked structure for longer-lasting results
- Origin: Non-animal-based, biodegradable HA
- Texture: Soft and highly viscoelastic
- Syringe Volume: 1.1 mL per prefilled syringe
The monophasic structure of REVOLAX Fine means the HA gel is consistent throughout, offering smooth extrusion, greater stability in tissue, and more uniform integration. This quality also improves ease of injection and allows for more controlled placement in delicate areas such as the periorbital region and upper lip.
Unlike biphasic fillers, monophasic HA has a more cohesive molecular structure, which contributes to reduced migration and improved durability once injected.
2. Clinical Indications
REVOLAX Fine with Lidocaine is indicated for the correction of superficial facial wrinkles and fine lines, particularly in areas with thin skin and low volume loss.
Primary treatment areas:
- Periorbital wrinkles (crow’s feet)
- Glabellar lines (frown lines)
- Perioral lines (smoker’s lines)
- Neck lines and superficial décolletage folds
- Light lip enhancement (contour definition)
- Forehead fine lines (carefully injected)
Because of its soft consistency, it is not recommended for deep volumizing or structural support—those indications are better suited to REVOLAX Deep or Sub-Q.
3. Patient Selection Criteria
Appropriate patient selection is key to obtaining optimal outcomes and minimizing complications. REVOLAX Fine is best suited for:
- Adults aged 25–55 with early signs of aging
- Patients seeking minimal, natural-looking corrections
- Individuals with fine skin texture or superficial wrinkles
- Non-smokers (preferable, due to skin healing)
Not ideal for:
- Deep nasolabial folds
- Midface volume restoration
- Structural reshaping of jawline or chin
4. Recommended Injection Protocol
A. Depth of Injection
- Superficial to mid dermis
- Avoid deep dermal or subcutaneous planes with this filler
B. Techniques
- Linear threading: for smooth correction along wrinkle lines
- Micro-bolus: for precise volume control
- Fanning: for horizontal lines such as neck or forehead
- Serial puncture: for delicate areas like glabella, upper lip
C. Needle Guidelines
- Supplied needle: 30G or 31G (included in box)
- Consider 32G for extra patient comfort in very superficial work
D. Injection Tips by Area
| Area | Recommended Technique | Volume per line | Notes |
|---|---|---|---|
| Crow’s feet | Linear threading | 0.01–0.03 mL | Avoid too lateral to preserve smile lines |
| Glabella | Serial puncture | 0.01 mL per point | High vascular risk, inject cautiously |
| Perioral lines | Microbolus | 0.02–0.05 mL | Inject superficially to avoid overcorrection |
| Neck lines | Fanning + threading | 0.03–0.1 mL per line | Work symmetrically and massage gently |
| Lip contour | Threading | 0.05 mL per side | Focus on vermillion border, not volume |
5. Longevity and Maintenance
- Duration: Typically 9–12 months in static areas
- Touch-ups: May be needed every 6–9 months in dynamic areas like lips or around the mouth
- Factors affecting longevity:
- Patient metabolism
- Skin type and age
- Area of injection
- Volume injected
- Technique and depth
REVOLAX Fine integrates gradually into the dermis and degrades evenly, avoiding sudden volume loss.
6. Post-Treatment Care Guidelines
- Apply ice for 5–10 minutes post-procedure
- Avoid makeup or creams for 12–24 hours
- No facial massage for 48 hours unless instructed
- Avoid excessive sun, heat (e.g., saunas), and strenuous exercise for 48 hours
Patients should be informed that minor swelling, redness, or bruising are normal and self-limiting. Visible results are immediate but final integration may take 3–5 days.
7. Safety Profile and Contraindications
Common Adverse Effects
- Local erythema
- Mild edema
- Bruising or tenderness
Rare but Serious Complications
- Nodules
- Infections
- Intravascular injection (risk highest in glabella)
Contraindications
- Hypersensitivity to lidocaine or HA
- Pregnancy or breastfeeding
- Immune disorders
- Ongoing anticoagulant therapy (relative)
Always aspirate before injecting in high-risk zones and have hyaluronidase available in the clinic.
8. Storage, Handling & Legal Compliance
- Temperature: Store between 2–25 ºC
- Shelf life: 24 months (unopened)
- Use immediately after opening
- Do not reuse syringes
- Ensure CE-marked batch from verified distributor
9. Manufacturer and Certification
- Manufacturer: Across Co., Ltd., Seoul, South Korea
- Certification: CE mark for Class III medical device
- Distribution in EU/UK: Through authorized aesthetic supply chains (check with local agencies)
10. Conclusion
REVOLAX™ Fine with Lidocaine offers a precise and efficient solution for treating fine lines and superficial wrinkles. Its monophasic, stable gel structure ensures even integration and natural aesthetics. With proper injection technique and patient selection, aesthetic professionals can achieve consistent, subtle, and satisfying outcomes.
In a landscape where cost-effectiveness and clinical performance are both essential, REVOLAX Fine provides a dependable and accessible choice. By following best practices in injection protocols, anatomical awareness, and post-care, injectors can ensure both safety and high patient satisfaction.
References
Gold, M. H. – Clinical Interventions in Aging
→ ✔️ Correcto, artículo académico en PubMed
REVOLAX UK – Before and After
→ ✔️ Correcto, sitio oficial de marca
Goodman et al. – CCID
→ ✔️ Correcto, publicación académica en Clinical, Cosmetic and Investigational Dermatology
Across Co., Ltd. – Official Website
→ ✔️ Correcto, sitio oficial del fabricante